15-96326466-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000421109.6(NR2F2):c.43+114G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00857 in 845,196 control chromosomes in the GnomAD database, including 303 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.030 ( 202 hom., cov: 32)
Exomes 𝑓: 0.0039 ( 101 hom. )
Consequence
NR2F2
ENST00000421109.6 intron
ENST00000421109.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.44
Genes affected
NR2F2 (HGNC:7976): (nuclear receptor subfamily 2 group F member 2) This gene encodes a member of the steroid thyroid hormone superfamily of nuclear receptors. The encoded protein is a ligand inducible transcription factor that is involved in the regulation of many different genes. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 15-96326466-G-T is Benign according to our data. Variant chr15-96326466-G-T is described in ClinVar as [Benign]. Clinvar id is 1291706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.102 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NR2F2-AS1 | NR_125738.1 | n.163+490C>A | intron_variant, non_coding_transcript_variant | |||||
NR2F2 | NM_001145155.2 | c.43+114G>T | intron_variant | NP_001138627.1 | ||||
NR2F2-AS1 | NR_102743.1 | n.163+733C>A | intron_variant, non_coding_transcript_variant | |||||
NR2F2-AS1 | NR_102744.1 | n.163+733C>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NR2F2-AS1 | ENST00000560800.5 | n.66+490C>A | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0300 AC: 4530AN: 150980Hom.: 200 Cov.: 32
GnomAD3 genomes
AF:
AC:
4530
AN:
150980
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00390 AC: 2706AN: 694102Hom.: 101 AF XY: 0.00322 AC XY: 1185AN XY: 367582
GnomAD4 exome
AF:
AC:
2706
AN:
694102
Hom.:
AF XY:
AC XY:
1185
AN XY:
367582
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0300 AC: 4535AN: 151094Hom.: 202 Cov.: 32 AF XY: 0.0287 AC XY: 2114AN XY: 73764
GnomAD4 genome
AF:
AC:
4535
AN:
151094
Hom.:
Cov.:
32
AF XY:
AC XY:
2114
AN XY:
73764
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
25
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at